type in your search and press enter
You May Also Like
Karyopharm Announces Agreement for Biogen to Acquire KPT-350 for the Treatment of Neurological and Neurodegenerative Conditions
− Biogen Brings Expertise in Development and Commercialization of Products for Neurological and Neurodegenerative ...
UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance
RA’ANANA, Israel, and NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...
Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn’s disease patients
PRESS RELEASE Takeda and TiGenix announce that Swissmedic has accepted for review the file ...
